Randomized Study Of Novel Enuresis Alarm vs Standard Bedwetting Alarm

Eligibility Criteria

• 1. Provision of signed and dated informed consent form
• 2. Stated willingness to comply with all study procedures and availability for the duration of the study
• 3. Male or female, aged 6 to 21 years
• 4. In good general health as evidenced by medical history and diagnosed with MNE
• 5. Ability to and be willing to adhere to the treatment regimen. -
• 1. No patient may have had treatment of MNE in the past 6 months whether with medications or alarms
• 2. Current use of on ADHD medications, Tricyclics, SSRI's, NRI's or any antipsychotic medications.
• 3. Presence of Autistic Spectrum disorder, ADHD, genetic syndrome associated with developmental or learning disabilities
• 4. Treatment with another investigational drug or other intervention within last 6 months
• 5. Any form of Diabetes Mellitus or Diabetes Insipidus
• 6. No patient with known Chronic renal disease with moderate to severe renal impairment (defined as a creatinine clearance below 50mL/min).
• 7. No patient with known hyponatremia or a history of hyponatremia.